Sign inJoin waitlistJoin the waitlist

DC

Demitra Canoutas

Credentials:

History

Residency
2022–2025
Medical School
2018–2022

Research

Combination therapy with potent PI3K and MAPK inhibitors overcomes adaptive kinome resistance to single agents in preclinical models of glioblastoma
Neuro-Oncology · 2017 · 52 citations
PIK3CA missense mutations promote glioblastoma pathogenesis, but do not enhance targeted PI3K inhibition
PLoS ONE · 2018 · 21 citations
Partnership Loss and Receipt of Guideline-adherent Biennial Mammography Screening
Journal of Community Health · 2026 · First of 5 authors

Alex Gertner
1 paper
Carey Anders
1 paper
CM
Christopher Miller
1 paper
Emily Stroobant
1 paper
Erik Sulman
1 paper
James Whiteside
1 paper
Jann Sarkaria
1 paper
Kelley Haven
1 paper
Michael Hadler
1 paper